These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 33062704)
21. Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma. Zhang L; Wang S; Wang L BMC Cancer; 2024 Oct; 24(1):1235. PubMed ID: 39375639 [TBL] [Abstract][Full Text] [Related]
22. Identification of CAV1 and DCN as potential predictive biomarkers for lung adenocarcinoma. Yan Y; Xu Z; Qian L; Zeng S; Zhou Y; Chen X; Wei J; Gong Z Am J Physiol Lung Cell Mol Physiol; 2019 Apr; 316(4):L630-L643. PubMed ID: 30604627 [TBL] [Abstract][Full Text] [Related]
23. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment. Yu L; Cao S; Li J; Han B; Zhong H; Zhong R Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738 [TBL] [Abstract][Full Text] [Related]
24. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment. Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038 [TBL] [Abstract][Full Text] [Related]
25. Key microRNAs and hub genes associated with poor prognosis in lung adenocarcinoma. Ye GC; Liu YF; Huang L; Zhang CY; Sheng YL; Wu B; Han L; Wu CL; Dong B; Qi Y Aging (Albany NY); 2021 Jan; 13(3):3742-3762. PubMed ID: 33461176 [TBL] [Abstract][Full Text] [Related]
26. Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma. Tian Y; Yu M; Sun L; Liu L; Wang J; Hui K; Nan Q; Nie X; Ren Y; Ren X J Comput Biol; 2020 Jul; 27(7):1067-1078. PubMed ID: 31750732 [TBL] [Abstract][Full Text] [Related]
27. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis. Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311 [TBL] [Abstract][Full Text] [Related]
28. KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis. Wang W; He J; Lu H; Kong Q; Lin S Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32519739 [TBL] [Abstract][Full Text] [Related]
29. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis. Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972 [TBL] [Abstract][Full Text] [Related]
30. Lipid metabolism gene-wide profile and survival signature of lung adenocarcinoma. Li J; Li Q; Su Z; Sun Q; Zhao Y; Feng T; Jiang J; Zhang F; Ma H Lipids Health Dis; 2020 Oct; 19(1):222. PubMed ID: 33050938 [TBL] [Abstract][Full Text] [Related]
31. Weighted gene co-expression network analysis of hub genes in lung adenocarcinoma. Luo X; Feng L; Xu W; Bai X; Wu M Evol Bioinform Online; 2021; 17():11769343211009898. PubMed ID: 33911849 [TBL] [Abstract][Full Text] [Related]
32. Identification of Three lncRNAs as Potential Predictive Biomarkers of Lung Adenocarcinoma. Jin D; Song Y; Chen Y; Zhang P Biomed Res Int; 2020; 2020():7573689. PubMed ID: 32149133 [TBL] [Abstract][Full Text] [Related]
33. Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases. Zheng Q; Min S; Zhou Q Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34017995 [TBL] [Abstract][Full Text] [Related]
34. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis. Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076 [TBL] [Abstract][Full Text] [Related]
35. Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma. Ren J; Wang A; Liu J; Yuan Q Bioengineered; 2021 Dec; 12(1):4331-4348. PubMed ID: 34338158 [TBL] [Abstract][Full Text] [Related]
36. Gene expression profiling using targeted RNA-sequencing to elucidate the progression from histologically normal lung tissues to non-invasive lesions in invasive lung adenocarcinoma. Kadonaga T; Sakabe T; Kidokoro Y; Haruki T; Nosaka K; Nakamura H; Umekita Y Virchows Arch; 2022 Apr; 480(4):831-841. PubMed ID: 35067776 [TBL] [Abstract][Full Text] [Related]
37. Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis. Yu L; Liang X; Wang J; Ding G; Tang J; Xue J; He X; Ge J; Jin X; Yang Z; Li X; Yao H; Yin H; Liu W; Yin S; Sun B; Sheng J Genet Res (Camb); 2023; 2023():6782732. PubMed ID: 36688087 [TBL] [Abstract][Full Text] [Related]
38. Identification Six Metabolic Genes as Potential Biomarkers for Lung Adenocarcinoma. Zhang S; Lu Y; Liu Z; Li X; Wang Z; Cai Z J Comput Biol; 2020 Oct; 27(10):1532-1543. PubMed ID: 32298601 [TBL] [Abstract][Full Text] [Related]
39. Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer. Shi Y; Zhu S; Yang J; Shao M; Ding W; Jiang W; Sun X; Yao N J Comput Biol; 2020 Sep; 27(9):1433-1442. PubMed ID: 32048869 [TBL] [Abstract][Full Text] [Related]
40. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development. Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]